More than 100 million people in the United States are living with prediabetes or diabetes. Prediabetes is a condition that can be reversed and it increases the risk of developing Type 2 diabetes, affecting approximately 34% of adults. Factors such as being overweight and leading a sedentary lifestyle contribute to the development of prediabetes.
Early identification of individuals with prediabetes can greatly reduce their chances of developing diabetes. Without any intervention, 37% of individuals with prediabetes may progress to diabetes within a span of 4 years. By making lifestyle changes, this risk can be reduced to 20%.
Studies conducted over a long period of time have shown that lifestyle interventions can prevent prediabetes from turning into diabetes for up to a decade. Investing in prevention programs now can lead to substantial cost savings in the future.
Understanding Prediabetes
According to national surveys, around 79 million American adults have prediabetes, a prevalence that is three times higher than that of diabetes. Diagnostic criteria for prediabetes include elevated fasting blood glucose levels, hemoglobin A1c values, and results from oral glucose tolerance tests.
Glucose Levels Guidelines
Here are the guidelines for diagnosing normal glucose levels, prediabetes, and diabetes:
| Test for Diabetes | ||
|---|---|---|
| Normal Levels | Prediabetic Range | Diabetic Levels |
| 100–125 |
| More than 125 |
Statistics show that a significant percentage of adults in the United States are at risk of developing diabetes, with approximately 35% of individuals over 20 years old and 50% over 65 years old having prediabetes. It is estimated that 5-10% of those with prediabetes will transition to diabetes each year.
To combat this growing problem, the American Diabetes Association suggests that adults over the age of 45 who are overweight and have other risk factors such as high blood pressure, low HDL cholesterol levels, family history of diabetes, or are part of certain ethnic groups should undergo diabetes screening.
According to data from Kaiser Permanente, which includes more than 8.5 million members, around 852,031 patients meet the criteria for prediabetes, with 81% of them being overweight or obese. This highlights the urgent need for preventive measures and screenings to address the rising prevalence of diabetes in the population.
| Geographical Area | Number of Participants in Diabetes Study Group | Percentage of Members Aged 10-75 Years | |||
| State | Area | Rank |
| Colorado | 32,973 square miles | 7th in size |
| State: | Hawaii |
| Population: | 34,997 |
| Islands: | 18 |
Based on information provided by Kaiser Permanente, a specific group has been identified to assess the risk of developing diabetes. This group includes active members between the ages of 10 and 75 with prediabetes indicators in their lab results. Individuals who have already been diagnosed with diabetes or who are deceased are not part of this analysis.
| Body mass index, kg/m 2 | Prevalence in Antelope Valley, % | Prevalence in Kern, % |
|---|---|---|
| More than 30 | 4403 (54) | 3534 (51) |
New research findings confirm a strong link between HbA1c levels and the risk of developing diabetes. People with HbA1c ≥ 6.0% are at a high risk of developing diabetes, with a 5-year risk ranging from 25% to 50%. The relative risk of diabetes is 20 times higher in individuals with HbA1c ≥ 6% compared to those with HbA1c < 5%. Even HbA1c levels of 5.5% to 6.0% increase the risk of diabetes. It is estimated that 70% of prediabetes cases progress to diabetes. In 2012, diabetes costs were estimated at $245 billion, with direct costs reaching $176 billion, mainly due to hospital care and medications. The average annual medical expenses for diabetes patients were $13,700, with $7900 specifically for diabetes-related costs. Indirect costs, such as reduced work productivity, were also significant. Studies have shown that organ damage associated with diabetes may begin during the prediabetes stage. Adults with diabetes incur significantly higher healthcare costs compared to those without diabetes.
Treatment
Lifestyle Intervention
The treatment of diabetes focuses on preventing complications rather than restoring normal blood glucose levels. Many diabetes diagnoses are delayed until complications arise, underscoring the importance of preventing diabetes and prediabetes. Lifestyle changes, such as weight loss and increased physical activity, can help prevent Type 2 diabetes. Research has shown that lifestyle interventions can reduce the incidence of diabetes compared to a placebo. These changes, including weight loss and physical activity, can significantly lower the risk of developing diabetes and can have a lasting impact over a decade.
Figure 1.
A comparison of the cumulative incidence of diabetes over four years in prediabetes patients with and without lifestyle modifications shows the effectiveness of lifestyle changes in reducing the risk of diabetes. Implementing lifestyle changes can prevent or delay the onset of diabetes.
A study in 2009 revealed that high-risk individuals for diabetes who underwent lifestyle interventions could still develop the disease. However, normalizing blood glucose levels reduced the risk of future diabetes. Lifestyle changes persistently reduced diabetes risk even after ten years. Both lifestyle modifications and drug interventions have been shown to lower the risk of developing diabetes. Group lifestyle interventions have demonstrated success in preventing or delaying diabetes over time.
- Effect of intensive blood-glucose control with metformin on complications in overweight individuals with type 2 diabetes (UKPDS 34). Lancet. 1998 Sep 12;352(9131):854–65.
- Early detection and diagnosis of diabetes mellitus in the United States. Diabetes Metab Res Rev. 2000 Jul-Aug;16(4):230–6. doi: 10.1002/1520-7560(2000)9999:99993.0.co;2-w.
- Reduction in new cases of type 2 diabetes with lifestyle changes or metformin. N Engl J Med. 2002 Feb 7;346(6):393–403. doi: 10.1056/NEJMoa012512.
- 10-year follow-up on diabetes rates and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009 Nov 14;374(9702):1677–86. doi: 10.1016/S0140-6736(09)61457-4.
- Regression from prediabetes to normal glucose regulation and long-term diabetes risk reduction. Lancet. 2012 Jun 16;379(9833):2243–51. doi: 10.1016/S0140-6736(12)60525-X.
- Diabetes prevention program (DPP): Type 2 diabetes and prediabetes. Available from: diabetes.niddk.nih.gov/dm/pubs/preventionprogram/
- Lifestyle interventions for patients with or at risk for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med. 2013 Oct 15;159(8):543–51. doi: 10.7326/0003-4819-159-8-201310150-00007.
- The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results. Diabetes Care. 2003 Dec;26(12):3230–6. doi: 10.2337/diacare.26.12.3230.
- Prevention of diabetes and reduction in major cardiovascular events in subjects with prediabetes: meta-analysis of clinical trials. Eur J Cardiovasc Prev Rehabil. 2011 Dec;18(6):813–23.
- Sustained reduction in type 2 diabetes incidence with lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006 Nov 11;368(9548):1673–9.
- Long-term effect of lifestyle interventions in preventing diabetes: a 20-year follow-up study. Lancet. 2008 May 24;371(9626):1783–9.
- Long-term effects of a 6-year lifestyle intervention in preventing diabetes-related microvascular complications. Diabetologia. 2011 Feb;54(2):300–7.
- Metformin treatment in individuals at risk for diabetes mellitus: a meta-analysis. Am J Med. 2008 Feb;121(2):149–57.
- Treating prediabetes with metformin: systematic review and meta-analysis. Can Fam Physician. 2009 Apr;55(4):363–9.
- Long-term effect of rosiglitazone and/or ramipril on diabetes incidence. Diabetologia. 2011 Mar;54(3):487–95.
- Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in individuals with impaired glucose tolerance or impaired fasting glucose. Diabetes Care. 2008 May;31(5):1007–14.
- Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes. Lancet. 2010 Jul 10;376(9735):103–11.
- Troglitazone. Handb Exp Pharmacol. 2010;(196):419–35.
- Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004 Dec 23;351(26):2683–93.
- Bariatric surgery and long-term cardiovascular events. JAMA. 2012 Jan 4;307(1):56–65.
- Personalized intervention for preventing type 2 diabetes mellitus. Perm J. 2013 Summer;17(3):74–9.
- Screening Adults for prediabetes and diabetes may be cost-saving. Diabetes Care. 2010 Jul;33(7):1484–90.
- A nationwide community-based lifestyle program could delay or prevent type 2 diabetes cases and save $5.7 billion in 25 years. Health Aff (Millwood) 2012 Jan;31(1):50–60.
- Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013 Jul 11;369(2):145–54.
- The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Biol Sci Med Sci. 2006 Oct;61(10):1075–81.
- Genetic factors in type 2 diabetes and implications for treatment. J Diabetes Sci Technol. 2009 Jul 1;3(4):690–6.
- Excess medical costs for patients with diabetes in a managed care population. Diabetes Care. 1997 Sep;20(9):1396–402.
- Managed care organization and the quality of diabetes care: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care. 2004 Jul;27(7):1529–34.
- Diabetes: successes and opportunities for prevention and control: at a glance 2011. Available from: www.cdc.gov/chronicdisease/resources/publications/aag/ddt.htm.